Sealed clinical trial kit shippers on a depot rack under flat north-window daylight, condensation on the steel bench below the line of cartons

Global Study Configuration

Someone has to read the vendor documentation closely.

Multinational trials add language, country-specific supply rules, and depot coordination across borders to RTSM configuration. This page walks through each in the order it surfaces during a study build.

RELEASED

Independent editorial — written for clinical operations teams evaluating RTSM vendors for studies that run beyond a single country.

Country Coverage

Country coverage is a specific number

"Global coverage" in vendor marketing is not a specific number, and it does not tell you how a country is served. Ask each vendor for a list of countries with a locally supported depot, then a second list of countries served through a regional hub. Those two lists behave very differently during a supply interruption.

A local depot can respond in days. A regional hub response depends on customs, import documentation, and the receiving site's local logistics. The distinction matters most for studies running in countries where import timelines are unpredictable.

Ask For Two Lists

Locally supported depot
A regional site with stock on hand. Response is measured in days, and the shipment rarely crosses a customs boundary.
Regional hub coverage
One hub serves many countries. Response time depends on customs, import documentation, and site-level receiving.

Three Screens To Check First

  • Randomization screen. The first screen a coordinator works from at a new site.
  • Resupply request. Language failure here turns into a phone call to the study team.
  • Unblinding workflow. The screen that must work at 2am in the site's own language.

Site-Facing Interface

Language support in the site interface

The site-facing interface is the part of the RTSM that coordinators actually touch, and it needs to work in the languages your sites use. That includes the randomization screen, the resupply request, and the unblinding workflow.

Ask the vendor which languages are supported out of the box and which are custom. Then ask how the language selection works per site, because a site in one country may have staff working in two or three languages. Vendors who handle this as a per-user setting tend to have better site feedback than vendors who require a per-country configuration.

Allocation Logic

Kit allocation rules across countries

Kit allocation rules that work in one country often do not survive contact with multinational supply. Each approach trades waste against documentation burden, and there is no universally correct answer — the question is whether the system supports the rule your protocol specifies without custom code.

01

Pooled allocation

Reduces waste across all sites. Requires depot visibility that many vendors do not support cleanly across borders.

02

Per-country reservation

Simplifies regulatory documentation at each site. Increases the total kit count and the discard load at study end.

03

Block or cohort

Matches the randomization scheme directly. Can produce odd depletion curves when enrolment is uneven across countries.

The decision that follows is how much of the rule can be changed after go-live if the enrolment pattern turns out differently than planned.

Freight apron at dusk with staged shipment pallets and low cool light, one worker walking between pallets with their back to the camera

Depot Coordination

The visibility problem across borders

Depot coordination is where most multinational supply problems appear. A shipment that leaves a regional hub on time can still arrive late because of customs or import documentation, and the site only learns about the delay when it tries to allocate the kit.

Systems that provide depot-level visibility let the study team see the shipment in transit and adjust enrolment or resupply before the site runs into a shortage. Systems that do not put the study team in a reactive posture.

Ask specifically how the system tracks in-transit shipments, and how a site can see whether a replacement kit is already on its way.

Emergency Unblinding

Across time zones

Emergency unblinding is straightforward in one country with a single support line. Across many countries it raises questions that have less to do with software than with the procedure the site follows when the sponsor's clinical lead is asleep.

Who is authorized
The procedure names which site staff can unblind at each country, and whether a second signature is required at some sites but not others.
After hours
The system verifies that authorization when the sponsor's clinical lead is asleep in another time zone. The verification path is what breaks first.
The record
How the unblinding is captured for the eventual safety review, so the record stands up to scrutiny once the study closes.

The procedures matter more than the software, though the software has to support them. Test the unblinding workflow from a site's perspective during UAT, ideally with a coordinator in a distant time zone, because that is where the workflow's weaknesses become visible.

Regulatory Variation

Country rules vary more than the workflow

Country-specific regulatory documentation for clinical supply can vary in ways that the RTSM configuration does not adapt to automatically. Kit labeling requirements, import documentation, and record-keeping obligations are usually the sponsor's responsibility, not the software's, but the RTSM has to accommodate whatever local rules apply.

Ask the vendor how they handle country-specific labeling in the kit allocation rules, and whether an unusual labeling requirement becomes a custom configuration or sits inside the standard product. The answer affects both your timeline and your amendment cost later in the study.

Where a country applies an unusual rule — a second-language label that must appear on every kit, or an import document that has to accompany each shipment — the RTSM needs to know about it at the kit-allocation level, not only at the label printer.

Add To UAT

What to test during multinational UAT

Add three scenarios to your UAT script when the study is multinational. Each covers a class of situation that surprises teams after go-live, and each is cheap to run before.

  1. Scenario One

    Run a site transaction in every study language

    From a site in that country where possible. Coordinators will find the untranslated field before the study team does.

  2. Scenario Two

    Simulate a depot shipment that arrives late

    Hold the expected date and see how the system presents the delay. If the site learns only when it tries to allocate, the visibility gap is real.

  3. Scenario Three

    Run one emergency unblinding from a distant site

    Using the actual after-hours procedure. Weaknesses in the workflow become visible within the first ten minutes.

Review study startup steps

The UAT script you bring to study startup is what shows where the vendor's coverage actually holds.

Match The List To Your Sites

Where the vendor's country list actually matters

The vendor's country coverage matters most where you are running sites in places with slower import timelines, unusual labeling requirements, or a small number of enrolled subjects spread across many locations. A study running only in Western Europe and the US will find most vendors adequate.

A study with sites in multiple regions and unpredictable shipment timelines will find the differences between vendors substantial. Match the vendor's actual coverage to your actual site list, not to a marketing map, and ask for a specific recent example in each country you need.

When Coverage Decides

  • Slower import timelines in the countries you are running.
  • Labeling requirements that are not covered by the standard product.
  • Small enrolment spread across many locations in different regions.
  • Shipment routes that cross customs more than once before reaching the site.

Ask the vendor for a specific recent example in each country you need, not for a coverage map.

Common Questions

What teams ask before a multinational build

The same four questions come up in almost every study with sites in more than one region. These are the answers we give before a scope discussion.

Does country coverage in vendor marketing tell us anything useful? +
Some, but not enough on its own. The marketing list usually counts countries where the vendor has run a study at some point. What you need is a list of countries served by a local depot and a second list served through a regional hub, because those behave differently when a shipment is delayed. Ask each vendor for both lists and cross-reference against your site locations.
How much does language support affect RTSM configuration time? +
It varies with the number of languages and how the vendor supports language selection. Vendors that handle language as a per-user setting are usually faster to configure than those that require per-country configuration. The bigger risk is not configuration time but whether the site-facing interface and the randomization screens are available in the languages your coordinators actually work in, which is a different question from the study's protocol languages.
What changes if a study spans multiple regions with different depot arrangements? +
Depends on whether the depot arrangement is visible in the RTSM or managed outside it. If the system tracks in-transit shipments and depot stock, the study team can anticipate delays. If not, the study team tends to react to site calls, which is slower and harder to plan around. For studies with unpredictable import timelines, this is often the deciding factor between two otherwise similar vendors.
How should emergency unblinding procedures change for multinational studies? +
The procedure needs to answer who is authorized at each site, how the system verifies that authorization after hours, and how the unblinding is recorded for safety review. Test the procedure during UAT with a coordinator in a distant time zone, ideally using the actual after-hours process. Most problems in this area are procedural rather than technical, and they show up quickly when tested with a real site rather than a study team member.

Editorial Provenance

Written for study teams, not for vendor marketing

This page is part of an independent editorial resource on RTSM, IRT, and clinical trial supply decisions. Nothing here is sponsored by a platform vendor, and the comparisons are drawn from the criteria study teams bring to a scope discussion. If a technical detail on this page reads differently than your own vendor documentation, the documentation wins — and we would rather correct the page than argue about it.